Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |